Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42


Evolutionary Transitions of MicroRNA-Target Pairs.

Nozawa M, Fujimi M, Iwamoto C, Onizuka K, Fukuda N, Ikeo K, Gojobori T.

Genome Biol Evol. 2016 Jun 4;8(5):1621-33. doi: 10.1093/gbe/evw092.


Therapeutic potential of targeting microRNA-10b in established intracranial glioblastoma: first steps toward the clinic.

Teplyuk NM, Uhlmann EJ, Gabriely G, Volfovsky N, Wang Y, Teng J, Karmali P, Marcusson E, Peter M, Mohan A, Kraytsberg Y, Cialic R, Chiocca EA, Godlewski J, Tannous B, Krichevsky AM.

EMBO Mol Med. 2016 Feb 9;8(3):268-87. doi: 10.15252/emmm.201505495.


Transcriptional activation of the IGF-II/IGF-1R axis and inhibition of IGFBP-3 by miR-155 in hepatocellular carcinoma.

El Tayebi HM, Waly AA, Assal RA, Hosny KA, Esmat G, Abdelaziz AI.

Oncol Lett. 2015 Nov;10(5):3206-3212. Epub 2015 Sep 18.


MtiBase: a database for decoding microRNA target sites located within CDS and 5'UTR regions from CLIP-Seq and expression profile datasets.

Guo ZW, Xie C, Yang JR, Li JH, Yang JH, Zheng L.

Database (Oxford). 2015;2015. pii: bav102. doi: 10.1093/database/bav102.


Emerging role of transcription factor-microRNA-target gene feed-forward loops in cancer.

Wu Q, Qin H, Zhao Q, He XX.

Biomed Rep. 2015 Sep;3(5):611-616. Epub 2015 Jun 11.


MiR-497 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting VEGFA and AEG-1.

Yan JJ, Zhang YN, Liao JZ, Ke KP, Chang Y, Li PY, Wang M, Lin JS, He XX.

Oncotarget. 2015 Oct 6;6(30):29527-42. doi: 10.18632/oncotarget.5012.


MicroRNAs and Noncoding RNAs in Hepatic Lipid and Lipoprotein Metabolism: Potential Therapeutic Targets of Metabolic Disorders.

Sud N, Taher J, Su Q.

Drug Dev Res. 2015 Sep;76(6):318-27. doi: 10.1002/ddr.21269. Epub 2015 Aug 19. Review.


MicroRNAs in B-cells: from normal differentiation to treatment of malignancies.

Marques SC, Laursen MB, Bødker JS, Kjeldsen MK, Falgreen S, Schmitz A, Bøgsted M, Johnsen HE, Dybkaer K.

Oncotarget. 2015 Jan 1;6(1):7-25. Review.


The role of microRNAs in nasopharyngeal carcinoma.

Tan G, Tang X, Tang F.

Tumour Biol. 2015 Jan;36(1):69-79. doi: 10.1007/s13277-014-2847-3. Epub 2014 Nov 27. Review.


Comprehensive luciferase-based reporter gene assay reveals previously masked up-regulatory effects of miRNAs.

Campos-Melo D, Droppelmann CA, Volkening K, Strong MJ.

Int J Mol Sci. 2014 Sep 3;15(9):15592-602. doi: 10.3390/ijms150915592.


MiR-103a-3p targets the 5' UTR of GPRC5A in pancreatic cells.

Zhou H, Rigoutsos I.

RNA. 2014 Sep;20(9):1431-9. doi: 10.1261/rna.045757.114. Epub 2014 Jul 1.


The panorama of miRNA-mediated mechanisms in mammalian cells.

Stroynowska-Czerwinska A, Fiszer A, Krzyzosiak WJ.

Cell Mol Life Sci. 2014 Jun;71(12):2253-70. doi: 10.1007/s00018-013-1551-6. Epub 2014 Jan 29. Review.


MicroRNAs as Haematopoiesis Regulators.

Undi RB, Kandi R, Gutti RK.

Adv Hematol. 2013;2013:695754. doi: 10.1155/2013/695754. Epub 2013 Dec 24. Review.


Biomarkers of chemotherapy-induced testicular damage.

Dere E, Anderson LM, Hwang K, Boekelheide K.

Fertil Steril. 2013 Nov;100(5):1192-202. doi: 10.1016/j.fertnstert.2013.09.017. Review.


SOT Symposium Highlight: Translatable Indicators of Testicular Toxicity: Inhibin B, MicroRNAs, and Sperm Signatures.

Dere E, Anderson LM, Coulson M, McIntyre BS, Boekelheide K, Chapin RE.

Toxicol Sci. 2013 Dec;136(2):265-73. doi: 10.1093/toxsci/kft207. Epub 2013 Sep 19.


MicroRNAs and liver cancer associated with iron overload: therapeutic targets unravelled.

Greene CM, Varley RB, Lawless MW.

World J Gastroenterol. 2013 Aug 28;19(32):5212-26. doi: 10.3748/wjg.v19.i32.5212. Review.


Intercellular adhesion molecule 1: recent findings and new concepts involved in mammalian spermatogenesis.

Mruk DD, Xiao X, Lydka M, Li MW, Bilinska B, Cheng CY.

Semin Cell Dev Biol. 2014 May;29:43-54. doi: 10.1016/j.semcdb.2013.07.003. Epub 2013 Aug 11. Review.


miR156- and miR171-binding sites in the protein-coding sequences of several plant genes.

Bari A, Orazova S, Ivashchenko A.

Biomed Res Int. 2013;2013:307145. doi: 10.1155/2013/307145. Epub 2013 Jul 11.


p53 regulates nuclear GSK-3 levels through miR-34-mediated Axin2 suppression in colorectal cancer cells.

Kim NH, Cha YH, Kang SE, Lee Y, Lee I, Cha SY, Ryu JK, Na JM, Park C, Yoon HG, Park GJ, Yook JI, Kim HS.

Cell Cycle. 2013 May 15;12(10):1578-87. doi: 10.4161/cc.24739. Epub 2013 Apr 25.


Differentiated miRNA expression and validation of signaling pathways in apoE gene knockout mice by cross-verification microarray platform.

Han H, Wang YH, Qu GJ, Sun TT, Li FQ, Jiang W, Luo SS.

Exp Mol Med. 2013 Mar 8;45:e13. doi: 10.1038/emm.2013.31.

Items per page

Supplemental Content

Write to the Help Desk